Atrial Fibrillation: News

• ESOC 2022 Thrombolysis Safe in Stroke Patients on Oral Anticoagulants A new observational study finds IV thrombolysis for acute stroke is safe for patients receiving direct oral anticoagulant therapy, prompting researchers to ask if current guidelines should be changed.
  Medscape Medical News, May 23, 2022
• Keeping Thyroid Hormone Treatment On Target Is Key for the Heart 'Both undertreatment and overtreatment were associated with adverse cardiovascular outcomes,' including higher mortality, but keeping thyroid hormone levels normal is a tricky task, researchers admit.
  Medscape Medical News, May 17, 2022
• Genetic Testing for Early Onset AF Yields Important Prognostic Information Adults with early onset atrial fibrillation often have rare genetic variants in cardiomyopathy and arrhythmia genes, and genetic testing can provide useful prognostic information, a new study suggests.
  Reuters Health Information, May 12, 2022
• ESOC 2022 Recurrent Stroke Risk High in AF, Even With Anticoagulants A new study has found dangerously high levels of stroke recurrence and death among patients who take DOAC or VKA therapy, which researchers say demonstrates an unmet medical need.
  Medscape Medical News, May 13, 2022
• Antithrombotic Therapies Shifting for Watchman LAA Occlusion National registry data show substantial deviation from the treatment protocols used in the pivotal randomized trials in the years following approval of the device.
  Medscape Medical News, May 05, 2022
• ACP-IM 2022 Bone, Breath, Heart, Guts: Eight Essential Papers in Primary Care At the 2022 ACP-IM meeting, editors from the Annals of Internal Medicine highlighted recent papers with key implications for internal medicine clinicians.
  Medscape Medical News, May 04, 2022
• HRS 2022 New Real-World Data Bolster Safety of Watchman FLX in LAAO Design changes that simplify deployment and recapture appear to give the next-generation device a sizeable advantage over the first Watchman 2.5 device.
  Medscape Medical News, May 02, 2022
• HRS 2022 Early EP Consult, Ordered in the ER, a Boon to AF Outcomes A simple intervention could potentially lead to faster and better care of patients with new-onset atrial fibrillation, making further ER visits less likely and prolonging survival, researchers say.
  Medscape Medical News, May 02, 2022
• HRS 2022 Why Are Numbers of Women, Minorities So Low in Cardiac EP? The very low number of women and individuals from ethnic minorities in the cardiac electrophysiology speciality in the United States has been highlighted in two new studies.
  Medscape Medical News, April 29, 2022
• HRS 2022 Cutting Dementia Risk in AF: Does Type of Rhythm Control Matter? The way sinus rhythm is restored in patients with atrial fibrillation might make a difference to risk for later dementia, suggests a cohort study that still leaves plenty of questions.
  Medscape Medical News, April 29, 2022
• Genetic Test for Six Chronic Diseases Undergoing Clinical Trial Researchers developed assays and supportive information to examine the expanded role of genetic information in patient care.
  Medscape Medical News, April 29, 2022
• Will You Suffer Cardiac Arrest? New Tech May Predict If and When Researchers at Johns Hopkins University want to create a 3D model of your heart to predict a life-threatening problem before it happens.
  WebMD Health News, April 26, 2022
• Vascepa's CV Mortality Benefit Magnified in MI Patients On top of statin therapy, icosapent ethyl provides mortality reductions in patients with prior MI.
  Medscape Medical News, April 26, 2022
• Study Points to Causal Role for Lp(a) in Atrial Fibrillation The relation is relatively modest but strongly argues for increased testing of Lp(a) and adding atrial fibrillation as a secondary outcome to ongoing trials, experts say.
  Medscape Medical News, April 20, 2022
• EHRA 2022 Pulsed Field Ablation Treats AF With Few Complications New-technology pulsed field ablation successfully isolated pulmonary veins with mini-mal complications to treat paroxysmal and persistent atrial fibrillation, a retrospective study has shown.
  Medscape Medical News, April 14, 2022
• EHRA 2022 Short, High-Power Ablation on Par With Standard AF Ablation Its efficacy and safety were comparable to conventional low-power, long-duration abla-tion, the randomized POWER FAST III trial showed.
  Medscape Medical News, April 13, 2022
• Zanubrutinib Shows Worth Against Standard CLL Drugs Patients with chronic lymphocytic leukemia could soon be offered a novel treatment option after trial data showed zanubrutinib improves outcomes against standard therapies.
  Medscape Medical News, April 13, 2022
• Alert FDA Approves Fitbit's AFib-Detection Software Fitbit has gained approval for an algorithm that will power an upcoming AFib-detection feature.
  FDA Approvals, April 12, 2022
• ACC 2022 New Smart Device Shows Highly Accurate AF Detection: mAFA II The study, conducted in a mass low-risk population in China, correctly identified atrial fibrillation in more than 93% of suspected cases detected.
  Medscape Medical News, April 12, 2022
• Physicians Assess Cardiovascular Safety of COVID-19 Vaccines After a review of the data, the Brazilian Society of Cardiology concluded that the benefits of vaccination outweigh the potential risks of thrombotic thrombocytopenia and myocarditis.
  Medscape Medical News, April 11, 2022